Active Pharmaceutical Industry: Upcoming Technological Innovations | Active Pharmaceutical Ingredients Market - The Pos | Page 7

The large share of this segment can be attributed to the emergence of new synthetic
molecules in the market, increasing number of new product approvals, less complex
manufacturing and approval processes as compared to biologics and technological
advancements in the method of synthesis.
However, the biotech APIs market is expected to grow at a substantially higher rate during
the forecast period owing to advances in biotechnology, growing demand for
biopharmaceuticals due to their specificity in action, their similarity with the natural
biological compounds, and significant growth in the demand for monoclonal antibodies.
Based on product, the biotech active pharmaceutical ingredients market is segmented
into monoclonal antibodies, hormones, vaccines, cytokines, fusion proteins, therapeutic
enzymes, and blood factors.
https://www.marketsandmarkets.com/Market-Reports/API-Market-263.html